| Surgery |
0 |
0.84 |
| Thromboembolism |
0 |
0.7 |
| Rheumatoid Arthritis |
0 |
0.52 |
| Clinical Guidelines |
0 |
0.47 |
| Systemic Lupus Erythematosus |
0 |
0.39 |
| Biologic Therapy |
0 |
0.32 |
| Arthritis |
0 |
0.16 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.14 |
| Hospital |
0 |
0.12 |
| Perioperative Care |
0 |
0.09 |
| Arthroplasty |
0 |
0.07 |
| Antineoplastic Drug |
0 |
0.06 |
| Joint Replacement |
0 |
0.06 |
| Monoclonal Antibody |
0 |
0.06 |
| Peer Review |
0 |
0.06 |
| Rheumatic Disease |
0 |
0.06 |
| Ankylosing Spondylitis |
0 |
0.03 |
| Board Certification |
0 |
0.03 |
| Cyclosporine |
0 |
0.03 |
| Fellowship |
0 |
0.03 |
| Interleukin |
0 |
0.03 |
| Lupus |
0 |
0.03 |
| Medicare |
0 |
0.03 |
| New York |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Patient History |
0 |
0.03 |
| Tissue |
0 |
0.03 |
| Venous Thromboembolism (VTE) |
0 |
0.03 |
| Wound |
0 |
0.03 |
| Wound Management |
0 |
0.03 |